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Summary: A prospective observational study was carried out to describe the pattern of pulmonary 
complications in hospitalized patients with Human Immune-deficiency Virus (HIV) infection at the 
University of Calabar Teaching Hospital, Calabar between January 2005 to December 2006. One 
hundred and twenty-four patients which consists 60 males and 64 females, aged between 20 – 60 who 
met the inclusion criteria formed the subjects for the study. The mean age of the subjects was 34.60+
1.2 years. A structured questionnaire was used to obtain the demographic data, clinical information and 
CD4 lymphocyte count. Radiological analysis of chest was done with the chest X-ray of each subject. 
Chronic productive cough topped the list of respiratory symptoms (89%) followed by chest pain (74%) 
and dyspnea (62%). Lung consolidation was the commonest respiratory sign as seen in 44% of the 
cases. Hilar lymphadenopathy was seen in (35%), Pleural effusion (32%), lung fibrosis (21%) and 
finger clubbing (15%). The clinical and radiological pattern of most patients with chronic cough was 
highly suggestive of mycobacterial infection such as tuberculosis, although only 40% of cases had 
positive Acid Fast Baccilli. The mean CD4 lymphocyte count level was 174.8 + 5.4 cells/l and this 
may be responsible for the respiratory findings as opportunistic lung infections are said to be 
commoner at CD4 count levels below 200 cells/l. However, four patients had mediasternal masses 
which may suggest neoplasms. Concerted efforts and continuous evaluation of these patients are 
needed to determine the spectrum of respiratory illnesses among HIV positive patients in Calabar.
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Introduction
Pulmonary complications have been one of 
he commonest causes of morbidity and 
mortality since the advent of Acquired Immune-
deficiency Syndrome (AIDS) (Afessa, 2001 and 
Murray et al, 1984). Seropositive patients 
nonetheless, are also prone to other infectious 
and non-infectious conditions. However, the 
type of pulmonary complications that develop 
depend on the degree of immnuo suppression 
(Huang, 1998). The pulmonary complications 
are also likely to vary according to geographical 
location, HIV risk factors, gender, race or 
ethnicity and social habits of patients. 
Respiratory symptoms which are frequent 
in HIV infected individuals may be due to a 
wide spectrum of diseases (GroupTpcoHis, 
1993). The spectrum of pulmonary illnesses in 
HIV infected patients include both opportunistic 
infections and neoplasms (Wallace et al, 1997). 
The opportunistic infections are caused by 
bacterial, mycobacterial, viral, fungal and 
parasitic pathogens.  A pilot study conducted in 
USA on the pulmonary complications of HIV 
infected patients demonstrated that respiratory 
symptoms are frequent complaints in HIV 
infected individuals and there was increase in 
frequency as the CD4 cell count declines below 
200cells/l (Wallace et al, 1993). However, 
such study has not been carried out in our 
environment, which has one of the highest 
prevalent rates of HIV infection in the country 
(FMOH, 2004). 
This study is therefore aimed at evaluating 
the pattern of respiratory complications amongst 
HIV seropositive patients seen at the University 
of Calabar Teaching Hospital over a 2-year 
period. Knowledge of the pattern of pulmonary 
complications in patients with HIV infection 
will help clinicians develop faster diagnostic 




A two-year prospective study (January, 
2005 – December, 2006) was carried out in 
Calabar to evaluate CD4 lymphocyte count
levels in HIV seropositive patients and pattern 
of respiratory complications amongst these 
patients. Confirmed HIV positive patients with 
CD4 count levels below 500cells/l who were 
receiving free Antiretroviral (ARV) treatment 
from Pepfar Clinic and subsequently admitted at 
the University of Calabar Teaching Hospital 
with respiratory complications were enrolled for 
the study within the period. 
A total of 124 patients, which consisted 60 
males and 64 females aged between 20 – 60, 
were used for the study. The mean age of 
patients was 34.60 + 1.2 years. Data on gender, 
age, marital status, occupational history, 
respiratory symptoms/signs, chest radiograph 
findings and CD4 lymphocyte count were 
collected. The investigators, physicians and 
radiologist reviewed all chest radiographs and 
the pattern of respiratory complications were 
noted after thorough clinical examination of the 
patients. Mycobacterial organisms were 
identified by Ziehl-Neelson stain only. Other 
bacterial organisms were cultured. However, it 
was not possible to culture mycobacterial, 
fungal, viral and parasitic organisms as there 
were no facilities in the hospital. 
Similarly, bronchoscopic examination on 
the subjects could not be done to ascertain 
definitive lung pathology due to lack of such 
facility. Antibiotic susceptibility tests were 
reviewed for cultured cases. Information on the 
bio-data, past medical history, social habits, and 
respiratory symptoms/signs were obtained using 
a prepared structured questionnaire 
administered to all patients. Data obtained were 
carefully documented in an information sheet 
prepared for each patient and analyzed with an 
Epi info version 6.0 software. All means were 
expressed with their standard deviation. 
However, no statistical analysis was done. 
Table 1: Demographical characteristics of the subjects 
Sex:
       Male 
       Female




       Single 
       Married 
       Widowed 






       <20 years 
       21 – 25 
       26 – 30 
       31 – 35 
       36 – 40 
       41 – 45 
       46 – 50 
       51 – 55 



































      Students 
      Businesspersons 
      Civil servants 
      Drivers 






Mean CD4 count = 173.85 + 5.4cells/l  
Mean age = 34.6 + 1.2 years 
Positive AFB = 25/62 (40%) 
Negative AFB = 32/62 (53%)
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Results 
One hundred and twenty-four patients 
which consisted of 60 males and 64 females
were enrolled for the study after meeting the 
inclusion criteria. The mean age of patients was 
34.60 + 1.2 years.  Table I shows the 
demographic characteristics of the subjects. 
Unmarried patients formed the bulk of the 
patients (53%) while the remaining patients 
were married, widowed or separated. Majority 
of the patients (29%) were in the age group 31 –
35 and about (80%) were below forty years of 
age. Students accounted for 24% of the patients 
surveyed, while private businesspersons were 
42%. Twenty-two (18%) of the subjects were 
drivers.  Table II illustrates the pattern of 
respiratory symptoms amongst the subjects 
surveyed. Chronic productive cough topped the 
list with 89%, followed by chest pain 74%, 
dyspnea 62% and sinusitis 37%. Non-
productive cough was seen in only 11% of the 
subjects surveyed while 18% had cough with 
haemoptysis. 
The pattern of respiratory signs and 
complications is shown in Table III. Lung 
consolidation was the commonest complication 
seen in 44% of the subjects surveyed and this 
was followed by hilar lymphadenopathy (35%), 
pleural effusion (32%), lung fibrosis (26%) and 
finger clubbing (15%). Mediasternal mass was 
seen in 4 (3%) of the patients. Positive AFB 
sputum examination was confirmed in only 
40% of the cases surveyed while 53% were 
negative. 
The CD4 lymphocyte count levels 
distribution of the subjects is as shown in Table 
IV. The mean CD4 count level was 173.85 +
5.1cells/l. The bulk of the patients (27%) had a 
CD4 count level between 151-200cells/l 
followed by a count between 101-150cells/l as 
seen in 21% of patients. Less than 20% of the 
cases surveyed had a CD4 count level greater 
than 200cells/l. 83% of the patients had a CD4
count of less than 200cells/l. 
Table 2: Respiratory symptoms 







110 (89) 54 (44) 56 (45)
Non-productive 
cough
14 (11) 6 (4) 8 (7)
Chest pain 92 (74) 44 (35) 43 (39)
Dyspnea 78 (62) 38 (30) 40 (32)
Haemoptis 22 (18) 12 (10) 10 (8)
Sinusitis 46 (37) 22 (18) 24 (19)
Table 3: Respiratory signs and diagnosis or complications 




Fibrosis 32 (26) 16 (13) 16 (13)
Pleural effusion 40 (32) 22 (18) 18 (14)
Consolidation 54 (44) 26 (21) 28 (25)
Lymphadenopathy 44 (35) 24 (19) 20 (16)
Finger clubbing 30 (24) 16 (13) 14 (11)
Mediasternal mass 4 (3) - 4 (3)
Table 4: CD4 Lymphocyte count level distribution (cells/l) 




0 – 50 24 (19) 14 (11) 10 (8)
51 – 100 20 (16) 16 (13) 4 (3)
101 – 150 26 (21) 8 (6) 18 (15)
151 – 200 34 (27) 14 (11) 20 (16)
201 – 250 6 (5) 4 (3) 2 (1.5)
251 – 300 4 (3) 2 (1.5) 2 (1.5)
>300 10 (8) 6 (5) 4 (3)
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Discussion
This study collected clinical, laboratory and 
radiological data in a prospective and 
standardized form to access the pattern of
respiratory complications in HIV seropositive 
patients in Calabar over a period of two years. 
The study intended to provide useful source of 
information on the pattern of respiratory 
illnesses in HIV infected patients in our 
environment. Subjects who reported chronic 
productive cough were 89%, chest pain 74% 
and shortness of breath 62%. These figures are 
higher than that reported by studies on the 
pulmonary complications of HIV infection in 
USA (Wallace, 1997; Moore and Charsson, 
1996). 
However, only 11% of the subjects had 
non-productive cough, which may clinically 
suggest infection by fungal infection such as 
pneumocystic carinii. This finding is quite 
different from studies reported in North 
America and Europe where P. carinii infection 
is the commonest type of non-mycobacterial 
infection seen in HIV infected patients (Stansell 
et al, 1997 and Delorenzo et al, 1991). 
Mycobacterial infection such as 
tuberculosis still remains the commonest type of 
respiratory infection in Nigeria as documented 
in other studies (Idoko et al, 1994; Idigbe et al,
1994 and Peters et al, 2005). This was also 
amply demonstrated in our study in which a 
significant percentage of the patients presented 
with chronic productive cough, haemoptysis and 
other constitutional symptoms suggestive of 
mycobacterial infection. Indeed, tuberculosis is 
the most common opportunistic infection 
associated with HIV worldwide (Daley et al,
1992).  The study also revealed that upper 
respiratory tract illnesses such as sinusitis and 
upper respiratory infection were not as common 
as documented in the pulmonary complications 
of HIV infection study in USA. These illnesses 
were found to be even more common than 
bacterial pneumonia and tuberculosis in that 
study (Wallace et al, 1997). 
However, lung consolidation was the 
commonest pattern of respiratory pathology 
elicited among the patient surveyed (44%). This 
may suggest the higher prevalence of 
pneumonia, which may be largely bacterial in 
origin than opportunistic pneumonia, which has 
the highest prevalence in other studies 
(Delorenzo et al, 1991 and Koracs et al, 1984).  
Pleural effusion was seen in 32% of the 
case while lung fibrosis was seen in 26%. These 
findings coupled with chronic productive cough 
in these patients may strongly suggest 
tuberculosis, which has been documented to be 
fairly common amongst HIV patient (Charsson 
et al, 1987). In this study, more than 50% of 
patients surveyed had negative AFB smear and 
this was similar to findings by Afessa on survey 
of African-American Patients in Pulmonary 
Complication study in USA (Afessa, 2001). 
However, tuberculosis can affect people with 
HIV no matter what level of their CD4 count, 
which means that tuberculosis can often occur 
years before other problems associated with 
HIV develop. Lymphadenopathy was seen in 
35% of the subject while mediasternal mass was 
found in only four patients with HIV but is 
more likely in those with CD4 count of less than 
200cells/l. In patients with HIV infection, 
about 20% may develop a malignancy (Beral 
and Weiss, 1991). 
The mean CD4 lymphocyte count in 
patients surveyed was 173.85 + 5.4cells/l. In 
patients not treated with highly active 
antiretroviral drugs, the CD4 cell count is an 
excellent indicator of an HIV infected patient’s 
risk of developing a specific opportunistic 
infection or neoplasm, presumable because it 
reflects the stage of HIV disease and degree of 
immuno compromise. Many respiratory 
illnesses such as upper respiratory tract 
infection, sinusitis, bacterial pneumonia and 
tuberculosis are more common in HIV infected 
persons than in immuno-competent ones. These 
diseases have occurred in HIV infected patients 
at all CD4 count ranges (Huang, 1998).
However, studies have shown that there is a 
higher prevalence of diseases such as bacterial 
pneumonia and tuberculosis as the CD4 count 
level declines (Wallace et al, 1997, and Hanson 
et al, 1995). This is consistent with findings in 
our study in which the mean CD4 count was 
below 200cells/l and about 90% of patients 
presented with chronic productive cough. Thus, 
knowledge of the CD4 count level in HIV 
patients is extremely useful in making 
differential diagnosis and suggesting a 
diagnostic and therapeutic plan. 
In addition, it is likely that demographic 
and regional differences will affect the spectrum 
of illnesses seen in our environment. This is 
because, few patients may be injection drug 
users, or on illicit drugs and homosexuality is 
still very uncommon. It has been well 
documented that a patient’s HIV transmission 
category and habits provide insights into the 
relative frequency of various HIV-related 
opportunistic infections and neoplasm (Afessa, 
2001 and Selwyn et al, 1997). 
A travel and residence history may provide 
further information about exposures to HIV 
infection and certain organisms. This may 
explain why a significant percentage of patients 
surveyed in our study were long distance 
drivers. This study had several limitations. 
Some important data such as cigarette smoking 
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and use of chemoprophylaxis were not 
collected. Similarly, invasive investigation like 
diagnostic bronchoscope was not performed and 
moreover there was no facility for culture and 
isolation of mycobacterial, viral, fungal and 
parasitic organisms. 
In conclusion, the study has described the 
spectrum of respiratory illnesses seen in HIV 
infected patients in Calabar. Respiratory 
infection still remains the commonest type of 
respiratory illnesses. The application of highly 
active antiretroviral treatment is likely to be 
associated with changes in type and severity of 
pulmonary complications that we see in these 
patients. The pulmonary complications are also 
likely to vary according to geographical 
locations, HIV risk factors and severity of 
immuno-suppression. It is therefore 
recommended that continuous monitoring of 
these patients be performed in order to ascertain 
the pulmonary complications that may develop. 
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